关于
Biomaterials is a multidisciplinary field that integrates biology, materials science, and engineering to design and develop substances that interact with biological systems. These materials, which can be natural or synthetic, are engineered to support, enhance, or replace biological functions, playing a pivotal role in medical and healthcare advancements. Researchers in biomaterials investigate their properties, biocompatibility, and applications in areas ranging from tissue engineering to drug delivery systems.
The scope of biomaterials encompasses cutting-edge technologies and innovative applications, including the development of smart and biodegradable materials, implants, and scaffolds for tissue regeneration. By enabling breakthroughs in regenerative medicine, prosthetics, and diagnostics, biomaterials contribute significantly to improving patient outcomes and addressing global health challenges. This field continues to evolve, driven by the pursuit of creating sustainable and functional solutions tailored to the complexities of human biology.

Why Publish with us?
- Global Visibility – Indexed in major databases
- Fast Peer Review – Decision within 14–21 days
- Open Access – Maximize readership and citation
- Multidisciplinary Scope – Biology, Medicine and Engineering
- Editorial Board Excellence – Global experts involved
- University Library Indexing – Via OCLC
- Permanent Archiving – CrossRef DOI
- Affordable APCs with discounts
- High Citation Potential
- Professional Layout & Author Support
现在哪些文章在热门?
研究文章
- Knowledge Discovery on Artificial Intelligence and Physical Therapy: Document Mining Analysis
- Wishful Thinking or Valuable Forecasts? The Value of Policy Rate Predictions in Sweden
- A Machine Learning-based Method for COVID-19 and Pneumonia Detection
- Investigation and Energy Modeling of New Generation Environmentally Friendly Energy Source Thorium Fueled Molten Salt Reactors
- Kinetic Study of the Removal of Reafix Yellow B8G Dye by Boiler Ash
- Study of the Histological Features of the Stroma of High-Grade Gliomas Depending on the Status of the Mutation in the IDH1 Gene
Advertisement